Literature DB >> 12925984

ThinPrep-processed fine-needle samples of breast are effective material for RNA- and DNA-based molecular diagnosis: application to p53 mutation analysis.

Pascaline Tisserand1, Coralie Fouquet, Véronique Marck, Christine Mallard, Monique Fabre, Philippe Vielh, Thierry Soussi.   

Abstract

BACKGROUND: Fine-needle sampling is the least invasive method of in vivo breast carcinoma sampling and can provide material for breast carcinoma diagnosis. The aim of the current study was to assess the accuracy of molecular diagnosis techniques using fine-needle sample (FNS) material stored in PreservCyt (Cytyc Corp., Boxborough, MA).
METHODS: The p53 tumor suppressor gene was chosen as a model because it can be used for DNA, RNA, and protein analysis. Molecular analysis was performed using a yeast functional assay and DNA sequencing. p53 accumulation was evaluated by immunocytochemistry.
RESULTS: DNA and protein analysis indicated that samples stored for periods of several months, either at room temperature, 4 degrees C, or -20 degrees C, can be processed reliably. For RNA-based diagnosis, samples were still intact after 5 months of storage in PreservCyt at 4 degrees C. In addition, using FNS material that was stored for 16 months at 4 degrees C, the authors detected p53 mutations with either the functional assay for separating alleles in yeast (an RNA-based functional assay) or direct cDNA sequencing.
CONCLUSIONS: Fine-needle samples stored in PreservCyt at 4 degrees C are very good material for molecular diagnosis techniques. In addition, it is feasible to adopt a strategy of storing excess FNS material to create cellular banks that will be invaluable for future gene studies. Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11258

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925984     DOI: 10.1002/cncr.11258

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Cost efficiency analysis of modern cytocentrifugation methods versus liquid based (Cytyc Thinprep) processing of urinary samples.

Authors:  E Piaton; K Hutin; J Faÿnel; M-C Ranchin; M Cottier
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

2.  Molecular profiling of thin-prep FNA samples in assisting clinical management of non-small-cell lung cancer.

Authors:  Daniela Petriella; Domenico Galetta; Vincenza Rubini; Eufemia Savino; Angelo Paradiso; Giovanni Simone; Stefania Tommasi
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

3.  Conventional liquid-based techniques versus Cytyc Thinprep processing of urinary samples: a qualitative approach.

Authors:  Eric Piaton; Jacqueline Faÿnel; Karine Hutin; Marie-Claude Ranchin; Michèle Cottier
Journal:  BMC Clin Pathol       Date:  2005-10-06

4.  p53 immunodetection of liquid-based processed urinary samples helps to identify bladder tumours with a higher risk of progression.

Authors:  E Piaton; J Faÿnel; A Ruffion; J G Lopez; P Perrin; M Devonec
Journal:  Br J Cancer       Date:  2005-07-25       Impact factor: 7.640

5.  Combined use of urinary Survivin detection and liquid-based cytology for the early diagnosis of bladder urothelial carcinoma.

Authors:  Xiaofeng Xu; Ping Li; Dian Fu; Zhifeng Wei; Song Xu; Feng Xu; Feng Tian; Jingping Ge; Zhengyu Zhang; Wen Cheng
Journal:  Oncol Lett       Date:  2018-03-22       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.